(S)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid tert-butyl ester hydrochloride is a chiral, heterocyclic organic compound. It features a 1,2,3,4-tetrahydroisoquinoline scaffold with a carboxylic acid group protected as a tert-butyl ester at the 3-position, and it is supplied as a hydrochloride salt. The (S)-enantiomer is of particular interest in asymmetric synthesis. This compound is primarily utilized as a key chiral building block in pharmaceutical research and development. Its tetrahydroisoquinoline core is a privileged structure found in numerous bioactive molecules, including potential drug candidates targeting neurological disorders, cardiovascular diseases, and as enzyme inhibitors. The chiral center and protected functional groups make it a versatile intermediate for constructing complex molecules with defined stereochemistry. As a high-purity chiral intermediate, it is commonly employed in the synthesis of more advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its use facilitates the introduction of the tetrahydroisoquinoline moiety into target molecules, streamlining synthetic routes in medicinal chemistry.